INS and fragile X syndrome: Consistently, two FXS patients clinically treated with metformin for 1 year showed significant improvement in their cognition and speech behavior (Protic et al., 2019), suggesting that correction of insulin signaling could provide an exciting new avenue for possible FXS therapeutic treatment.